(Yicai) March 23 -- For more than a decade, the promise of artificial intelligence in biotechnology has centered on discovery ...

IBT's Ailsa Craig and Marek Poszepczynski give their key stock picks as companies move on from the science to commercial ...

In the latest meeting minutes released by the US Food and Drug Administration (FDA), the agency noted that significant ...

Jeremiah Kelly and Justin Coen joined Faegre Drinker as partners in its government and regulatory affairs practice in Washington, DC, the firm announced Wednesday.

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...

Equities generally moved higher during the fourth quarter of 2025, seemingly fueled by continued optimism around artificial ...

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

About 2 million Americans have a heart condition called “ paroxysmal supraventricular tachycardia ,” or PSVT. An electrical ...

For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

ASX biotech shares are trading at valuations that lag those of the US Nasdaq index. This discrepancy won't last, experts say.

A small biotech was forced to being winding down its operations after the FDA abruptly postponed a key meeting for four ...

Good afternoon, and welcome to the Health Brief newsletter. A brief appearance from spring has given way to gloomy weather in ...